AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression
Authors:
- Junxia ZhangJZJunxia Zhang
- Xiaomin QianXQXiaomin Qian
- Lei HanLHLei Han
- Kailiang ZhangKZKailiang Zhang
- Luyue ChenLCLuyue Chen
- Jilong LiuJilong Liu
- Yu RenYRYu Ren
- Ming YangMYMing Yang
- Anling ZhangAZAnling Zhang
- Peiyu PuPPPeiyu Pu
- Chunsheng KangCKChunsheng Kang
- 1 September 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (17) , 5519-5531
Abstract
The extensive involvement of miRNAs in cancer pathobiology has opened avenues for drug development based on oncomir inhibition. Dicer is the core enzyme in miRNA processing that cleaves the terminal loop of precursor microRNAs (pre-miRNAs) to generate mature miRNA duplexes. Using the three-dimensional structure of the Dicer binding site on the pre-miR-21 oncomir, we conducted an in silico high-throughput screen for small molecules that block miR-21 maturation. By this method, we identified a specific small-molecule inhibitor of miR-21, termed AC1MMYR2, which blocked the ability of Dicer to process pre-miR-21 to mature miR-21. AC1MMYR2 upregulated expression of PTEN, PDCD4, and RECK and reversed epithelial–mesenchymal transition via the induction of E-cadherin expression and the downregulation of mesenchymal markers, thereby suppressing proliferation, survival, and invasion in glioblastoma, breast cancer, and gastric cancer cells. As a single agent in vivo, AC1MMYR2 repressed tumor growth, invasiveness, and metastasis, increasing overall host survival with no observable tissue cytotoxicity in orthotopic models. Our results offer a novel, high-throughput method to screen for small-molecule inhibitors of miRNA maturation, presenting AC1MMYR2 as a broadly useful candidate antitumor drug. Cancer Res; 73(17); 5519–31. ©2013 AACR.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep SequencingCancer Research, 2011
- NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptorsCarcinogenesis, 2010
- Roles of small RNAs in tumor formationTrends in Molecular Medicine, 2010
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN statusLaboratory Investigation, 2010
- Many roads to maturity: microRNA biogenesis pathways and their regulationNature Cell Biology, 2009
- The evolution of our thinking about microRNAsNature Medicine, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene SilencingCell, 2005
- Identification of hundreds of conserved and nonconserved human microRNAsNature Genetics, 2005